18th Feb 2014 10:20 am |
RNS |
Blocklisting Interim Review |
12th Feb 2014 1:47 pm |
RNS |
Additional Listing |
10th Feb 2014 5:00 pm |
RNS |
Presenting at Leerink Global Healthcare Conference |
5th Feb 2014 7:00 am |
RNS |
Q1 2014 Financial Results and Operational Progress |
31st Jan 2014 3:17 pm |
RNS |
Holding(s) in Company |
29th Jan 2014 7:00 am |
RNS |
Notice of Results |
17th Jan 2014 5:11 pm |
RNS |
Holding(s) in Company |
16th Jan 2014 11:13 am |
RNS |
Additional Listing |
15th Jan 2014 4:34 pm |
RNS |
Holding(s) in Company |
15th Jan 2014 4:33 pm |
RNS |
Holding(s) in Company |
14th Jan 2014 4:23 pm |
RNS |
Closing of U.S. Follow-on Offering of Nasdaq ADSs |
14th Jan 2014 7:00 am |
RNS |
Agreement with Ipsen for Sativex in Latin America |
13th Jan 2014 5:00 pm |
RNS |
Holding(s) in Company |
13th Jan 2014 5:00 pm |
RNS |
Holding(s) in Company |
9th Jan 2014 7:00 am |
RNS |
Raises $87.9m on NASDAQ in U.S. Follow-On Offering |
6th Jan 2014 12:18 pm |
RNS |
Results of General Meeting |
6th Jan 2014 12:13 pm |
RNS |
Files Amendment to Registration Statement |
20th Dec 2013 2:05 pm |
RNS |
Notice of General Meeting and Follow-On Offering |
11th Dec 2013 7:00 am |
RNS |
U.S. Patent Allowance for Cannabinoids in Glioma |
6th Dec 2013 5:52 pm |
RNS |
Publication of UK Annual Report and Accounts |
2nd Dec 2013 7:00 am |
RNS |
Presenting at Piper Jaffray Health Care Conference |
29th Nov 2013 2:00 pm |
RNS |
Blocklisting Application |
27th Nov 2013 7:00 am |
RNS |
Sativex Regulatory Approval in Switzerland |
26th Nov 2013 5:51 pm |
RNS |
Director/PDMR Shareholding |
26th Nov 2013 7:00 am |
RNS |
Filing of U.S. Annual Report on Form 20-F |
19th Nov 2013 7:00 am |
RNS |
Final Results |
18th Nov 2013 6:00 pm |
RNS |
GW Presenting at Jefferies Healthcare Conference |
15th Nov 2013 7:00 am |
RNS |
Update on Epidiolex in Childhood Epilepsy |
12th Nov 2013 7:01 am |
RNS |
Notice of Results |
11th Nov 2013 7:00 am |
RNS |
Phase 1b/2a trial for Glioblastoma Multiforme |
21st Oct 2013 7:00 am |
RNS |
Successful Closing of Mutual Recognition Procedure |
2nd Oct 2013 8:00 am |
RNS |
New Sativex Data at ECTRIMS |
24th Sep 2013 2:01 pm |
RNS |
Grant of Options |
23rd Sep 2013 11:41 am |
RNS |
Agreement on Sativex Pricing in Germany |
20th Sep 2013 7:00 am |
RNS |
Presenting at Aegis Capital Healthcare Conference |
18th Sep 2013 7:00 am |
RNS |
GW Commences Trial of GWP42006 for Epilepsy |
19th Aug 2013 7:00 am |
RNS |
Blocklisting Interim Review |
14th Aug 2013 7:00 am |
RNS |
Investigational New Drug Application for Sativex |
8th Aug 2013 7:00 am |
RNS |
Presenting at the Canaccord Genuity Conference |
5th Aug 2013 7:00 am |
RNS |
2013 Third Quarter Financial Results |